CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
Yong-Soo Byun, Chang Rae Rho, Kyungjin Cho, Jin A Choi, Kyung Sun Na, Choun-Ki Joo
Korean J Ophthalmol. 2011;25(6):369-374.   Published online November 22, 2011
DOI: https://doi.org/10.3341/kjo.2011.25.6.369

Excel Download

Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
Yong-Soo Byun, Chang Rae Rho, Kyungjin Cho, Jin A Choi, Kyung Sun Na, Choun-Ki Joo
Korean Journal of Ophthalmology. 2011;25(6):369   Crossref logo
Link1 Link2 Link3
<p>Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease</p>
Vinod Burade, Rishit Zalawadia, Alpesh Patel, Abayomi Ogundele
Clinical Ophthalmology. 2020;Volume 14:2747-2755   Crossref logo
Link1 Link2
The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
Karl Stonecipher, Gail Torkildsen, George Ousler, Scot Morris, Linda Villanueva, David Hollander
Clinical Ophthalmology. 2016;887   Crossref logo
Link1
Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients
Karl Stonecipher, Jenny Chia, Ahunna Onyenwenyi, Villanueva, David Hollander
Therapeutics and Clinical Risk Management. 2013;409   Crossref logo
Link1
Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
Cynthia Matossian, William Trattler, Jennifer Loh
Clinical Ophthalmology. 2021;Volume 15:1979-1984   Crossref logo
Link1 Link2
Hyaluronic Acid/Trehalose Ophthalmic Solution in Reducing Post-Cataract Surgery Dry Eye Signs and Symptoms: A Prospective, Interventional, Randomized, Open-Label Study
Rita Mencucci, Eleonora Favuzza, Giulia Decandia, Michela Cennamo, Fabrizio Giansanti
Journal of Clinical Medicine. 2021;10(20):4699   Crossref logo
Link1
Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
Tatiana Deveney, Penny A Asbell
Clinical Ophthalmology. 2018;Volume 12:569-576   Crossref logo
Link1 Link2
A Multicenter, Open-Label, 52-Week Study of 2% Rebamipide (OPC-12759) Ophthalmic Suspension in Patients With Dry Eye
Shigeru Kinoshita, Saki Awamura, Norihiro Nakamichi, Hiroyuki Suzuki, Kazuhide Oshiden, Norihiko Yokoi
American Journal of Ophthalmology. 2014;157(3):576-583.e1   Crossref logo
Link1 Link2
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626.
Kenneth Sall, Onex Dara Stevenson, Thomas K Mundorf, Brenda L Reis
Ophthalmology. 2000;107(4):631-639   Crossref logo
Link1 Link2
Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
Michelle K Rhee, Francis S Mah
Clinical Ophthalmology. 2017;Volume 11:1157-1166   Crossref logo
Link1 Link2